BRIDGE BIOTHERAPEUTICS, INC. Organization of Investor Relations Event
| 1. Date & Time | Opening Date | Time | |
| From | To | From | To |
| 2021-12-29 | 2021-12-29 | 16:00 | 17:00 |
| 2. Place | Online(Click meeting) | ||
| 3. Participant | Institutional investors, retail investors, analysts, media | ||
| 4. Purpose | Clinical update on BBT-176 (a potential fourth-generation EGFR TKI) and a summary of the company's 2022 strategy | ||
| 5. Method |
The presentation will be webcast live through ClickMeeting, and the registration is available at the link below. *(https://bridgebio.clickmeeting.com/-ir-2021-12-29/register) | ||
| 6. Major Contents | Clinical update on BBT-176, summary of the company's 2022 strategy and a Q&A session | ||
| 7. Sponsor | Bridge Biotherapeutics, Inc. | ||
| 8. Opening Decision Date | 2021-12-22 | ||
| 9. Person in charge of IR | Department(Name) | Investor Relations (Michael Cho) | |
| Contact Number(Fax Number) | 031-8092-3280(031-8092-3284) | ||
| 10. IR Material Publication | Publication Date | 2021-12-29 | |
| Publication Place |
Presentation content and slides will be available through our website on 2021-12-29 date - KRX's KIND(Korea Investor's Network for Disclosure) System (http://kind.krx.co.kr) - www.bridgebiorx.com ▶Investor ▶Presentations & Events |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Bridge Biotherapeutics Inc. published this content on 22 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 December 2021 01:42:03 UTC.
